GIRISH K. MALHOTRA, P.E.     29150 Bryce Road, Pepper Pike, OH 44124        

 

Tel: 216-288-6489; 216-292-0626, e-mail: girish@epcotint.com


CAREER SUMMARY

60 years’ experience in Specialty, Custom, Fine Chemicals, Pharmaceuticals, Intermediates, Corrosion Inhibitors, Dye Intermediates, Food Additives, Flavors and Fragrances, Custom Chemicals, Resins, Coatings, Self Adhesive Products and Digital Imaging businesses.


PROFESSIONAL EXPERIENCE AND ACCOMPLISHMENTS


·       Scaling up new products and coating methodologies.

·       Identified and outlined methods to achieve savings of about $1 million per year for an electronic chemical client.

·       Quadrupled capacity and reduced manufacturing cost by 40% for fluoro-polymers and surfactants at minimal investment.

·       Presented a technology that allows production of “colored liquids” without taking a sample “off-line” (traditional method) resulting in 15-25 %    profitability improvement in GDP equivalent growth industries.

·       Reduced batch cycle time at an operation by 80% using a commercially available non-conventional technology that is about 25% of the cost of conventional technology.

·       Developed and commercialized trivalent chrome corrosion inhibitors. 

·       Completed a global corrosion inhibitor study for a global multinational chemical company. Identified cost reduction opportunities.

·       Developed and optimized electroplating chemical processes saving 25% cost.

·       Improved operating efficiency of a waste treatment plant by 40% without any investment

·       Established global leadership by developing strategic alliances in digital imaging with 50% gross margin.

·       Improved product development process to reduce time to market to three months from nine months for self-adhesive product line.

·       Maximized global patent protection and coverage to achieve exclusive relationship with customers.

·       Managed worldwide technology transfer for self-adhesives.

·       Tracked and evaluated self-adhesive and digital imaging technologies and recommends business opportunities.

·       Conceptualized and directed development of a single ply battery label with battery tester.

·       Rationalized and reduced Dutch Boy Brands SKU’s by 14% and identified 30% SKU reduction without loss of any business.

·       Conceived and commercialized a unique “convenience” home repair package for the retail market. Conducted due diligence to acquire pilot plant for Sherwin Williams.

·       Devised decentralization plan for corporate and division research and development efforts.

·       Tested and implemented equipment resulting in 25% lower re-labeling cost and higher quality paints. 

·       Conceptualized and demonstrated continuous paint manufacturing process producing consistent quality paint leading to raw material consolidation and lower cost.

·       Conceptualized, developed, tested, and implemented a semi-continuous paint manufacturing process that reduced costs by 40%.

·       Managed program to recycle obsolete paint to new products and other uses.

·       Conceived technology for continuous production of emulsion latex, alkyd, polyester, epoxy, and phenolic resins. Developed chemistries and demonstrated process feasibility. 

·       Managed program to recycle obsolete paint to new products and other uses.

·       Managed chemical plant profitability from -3.7% to 7% in two years, by improving productivity, and reducing manufacturing costs and inventories.

·       Coordinated with Sales and Marketing to increase site revenue by $5 million in one year.

·       Implemented processing changes to double resin capacity and reduced operating time by 40% without any investment.

·       Reduced manufacturing cost of an antioxidant and saved $3.5 million.

·       Reduced antioxidant cost by 30% and doubled capacity without any capital investment.

·       Directed start-up of food grade antioxidant plant.

·       Met 110% of manufacturing plan while operating at 85% of budget.

·       Established quality circles; increased capacity without capital and saved over $500,000 per year.

·       Increased chemical intermediate capacity by 75% with a $40,000 investment, adding $1 million per year to factory profit.

·       Implemented Six Sigma type operating methods and procedures in 1979-80 to improve corrosion inhibitor product capacity and quality resulting in doubling business.  

·       Directed and provided support to Manufacturing to reduce cost, improve quality and capacity increase to meet increased market needs.

·       Developed and commercialized new custom chemicals.

·       Developed hydrocarbon emission standards for State of Illinois.

·       Developed Air pollution permit system for State of Illinois.

·       Designed ethylene plants for Exxon.

·       Conceptualized ethylene production from petroleum residue.



POSITION, RESPONSIBILITIES AND TITLES



EPCOT International - Pepper Pike, OH                                           1996- Present



 

Privately held consulting company: improves manufacturing efficiencies, quality, promotes pollution prevention and strategic alliances; supply chain management; sources raw materials globally in Specialty, Pharmaceuticals, Fine Chemicals, Coatings, Resin and Textiles businesses.



 

President

 

Consultant US FDA: Pharmaceutical Science and Clinical Pharmacology Advisory Committee

November 2011

 

MORGAN ADHESIVES CO. (MACtac) - Stow, OH                    1991 – 1996



 

$400 million plus international division of Bemis Co., manufacturer of flexible packaging films and specialty coated pressure sensitive products.



 

Director, Corporate Research & Technology

 

THE SHERWIN-WILLIAMS COMPANY - Cleveland, OH          1973 – 1991



 

$3.2 billion dollar architectural, industrial, and automotive coatings company.    



 

Consumer Division: $2.5 billion architectural and industrial coating producing division.



 

·       Business Development Project Director (1987 - 1991)


·       Director, Process Engineering (1985 - 1987)


·       Plant Manager, Antioxidants and Resins - Fords, NJ (1983 - 1985)

·       Technical Director, Antioxidants and Resins - Fords, NJ (1981 - 1983)

·       Production Area Manager, Corrosion Inhibitors & Intermediates - Cincinnati, OH (1979-1981)


·       Group Leader/Senior Process Engineer (1973 - 1979)

 

EPA, STATE OF ILLINOIS - Springfield, IL                           1971 – 1973
Environmental Protection Engineer

 

EXXON - Florham Park, NJ                                              1968 – 1971


Process Engineer

 

PATENTS, PUBLICATIONS AND QUOTATIONS



1.        US Patent # 4,269,987 issued on May 26, 1981

2.        Numerous technology innovations disclosed and not filed to protect process inventions.

3.        Malhotra, Girish: Continuous vs. Batch Manufacturing, Paint and Coatings Industry, February 1999, Pages 100-103

4.        Malhotra, Girish: Viewpoint: The Coating Industry’s Challenge for the New Millennium, Modern Paint & Coatings, October 1999, Page 60

5.        Malhotra, Girish; Peixoto, Carlos A; Schotgues, Eduardo; Pfeil, Paulo R; The Color of   Money: New technology helps improve coatings production efficiency and profitability, Modern Paint & Coatings, Feb. 2001, Page 22-24.

6.        Malhotra, Girish; Peixoto, Carlos A; Schotgues, Eduardo; Pfeil, Paulo R; In-line measurement and correction of Color and physical properties; 7th Nürnberg Coatings Conference, Nürnberg April 7-8, 2003 Page 581-593 

7.        Malhotra, Girish; Peixoto, Carlos A; Schotgues, Eduardo; Pfeil, Paulo R; In-line measurement and correction of Color and physical properties; Symposium on Color and Appearance Instrumentation, April 15-16, 2003, Chicago, IL

8.        Malhotra, Girish: Process Puzzler: Maintaining Pump Prime: De-gas the ammonia; Chemical Processing, May 2004, pg. 38

9.        Malhotra, Girish: Process Puzzler: Take out Torque Slowly add fine powder: Chemical Processing, October 2004, pg. 50

10.      Malhotra, Girish; Peixoto, Carlos A; Schotgues, Eduardo; Pfeil, Paulo R; New Paradigm For Coating Manufacturing Processes; International Coatings Exposition October 25-29, 2004, Chicago, IL

11.      Malhotra, Girish: Coating manufacturing processes: Yesterday, today and tomorrow, Jan 5, 2005 http://specialchem4coatings.com

12.      Malhotra, Girish: Dispersion Equipment – an overview; March 2, 2005 http://www.specialchem4coatings.com/

13.      Malhotra, Girish: Multicell Technology; Annual R&D Council and Operations Management Meeting for a major coating company; March 2005

14.      Malhotra, Girish: Batch or a Continuous Process: A Choice; Pharmaceutical Processing, March 2005, Page 16

15.      Malhotra, Girish: Process Puzzler: Stop Solvent losses; Chemical Processing, March 2005, Page 45

16.      Malhotra, Girish: Process Puzzler: Choose a pump wisely: Chemical Processing

17.      Malhotra, Girish: Volatile Organic Compounds (VOC) regulations and Coating Industry, May 2005 http://specialchem4coatings.com

18.      Malhotra, Girish: Process Puzzler: Know when the end is near: Chemical Processing, June 2005, Page 39

19.      Chemical Week India Looks to Ethical Drugs, June 15, 2005, Page 27 http://www.chemweek.com/inc/articles/t/2005/06/15/029.html 

20.      Malhotra, Girish, Less is More in API Process Development: Pharmaceutical Manufacturing, July/August 2005, Pages 50-51

21.      Malhotra, Girish: Process Puzzler: Vanquish material variations: Chemical Processing, July 2005, Page 45

22.      Malhotra, Girish: Process Puzzler: Remove the fatty oil first: Chemical Processing, August 2005, Page 54

23.      Malhotra, Girish ADVISORY COMMITTEE FOR PHARMACEUTICAL SCIENCE, October 26, 2005 http://www.fda.gov/ohrms/dockets/ac/05/slides/2005-4187OPH2_01_Malhotra.ppt

24.      Malhotra, Girish: API Manufacture-Simplification and PAT:  Pharmaceutical Processing, November 2005, Pages 24-27

25.      Malhotra, Girish: Process Puzzler: Prevent heat-exchanger plugging: Recycle concentrated solution: Chemical Processing, November 2005, Page 52

26.      Malhotra, Girish: Simplification is Profitability: Pharmaceutical Technology, December 2005, Pages 14-16

27.      Malhotra, Girish: Pharma’s Changing workforce, Pharmaceutical Manufacturing, November/December 2005, Page 11

28.      Malhotra, Girish: Making sense of temperature sensing: Poor Mixing? Chemical Processing January 2006

29.      Malhotra, Girish: Indian Firms Tear Into Overseas API Markets, Chemical Week February 15, 2006, Pg 27- 36.

30.      Malhotra, Girish: Engineering, innovation, national well-being. Chemical Engineering March 2006 Page 8

31.      Malhotra, Girish: Fine Chemical Failures. Chemical Week, May 17, 2006, Page 5

32.      Malhotra, Girish: Pharma Intermediates: M&A Frenzy Takes Hold, Chemical Week May 31, 2006, Page 33

33.      Malhotra, Girish: Process Puzzler: Boost the reliability of a solvent supply pump- Use eccentric reducers: Chemical Processing, May 2006

34.      Malhotra, Girish: Process Puzzler: Uncovering cause of solid build-up- Look at the material balance: Chemical Processing, September 2006

35.      Malhotra, Girish: Indian Firm First to Gain FDA Approval for Pharma Formulation Intermediate, Chemical Week, September 20, 2006, Page 52

36.      Malhotra, Girish: Process Puzzler: Automation – a boost to morale: Chemical Processing, November 2006, Page 50

37.      Malhotra, Girish: QBD: First Things First, Pharmaceutical Manufacturing, November/ December 2006, Page 9

38.      Malhotra, Girish: Process Puzzler: Sticky Valve-Focus on heat tracing failure: Chemical Processing, January 2007, Page 52

39.      Chemical Week: Pharma Manufacturers Chase Greener, Cost-Efficient Chemistries, February 7, 2007, Page 21, Week

40.      Malhotra, Girish: QBD: Myth or Reality? Processing, February 2007, Pages 10-16

41.      Malhotra, Girish: Process Puzzler: Quick fix needed! Eventually, do a redesign Chemical Processing, May 2007, Page 42 

42.      Malhotra, Girish: Can Pharma Learn From the Unfolding Gluten Contamination Story? Pharmaceutical Manufacturing, May 3, 2007

43.      Malhotra, Girish: Big Pharma and Lessons From Detroit’s Big Three: Focus on API Manufacturing, Or Lose Your Edge to Offshore Generics, Pharmaceutical Manufacturing, May 16, 2007

44.      Malhotra, Girish: Continuous Processes Maintain Profitability, Drug Discovery and Development, June 2007, Pages 30-31

45.      Malhotra, Girish: Big Pharma: Who's Your Role Model, Toyota or Edsel? Pharmaceutical Manufacturing, June 2007, Page 40 

46.      Malhotra, Girish: Change is needed, GLG Group Analysis, July 16, 2007

47.      Malhotra, Girish: Can Indian Pharmaceutical companies be a threat? GLG Analysis July 27, 2007

48.      Malhotra, Girish: ICI a British Gem is sold GLG Group Analysis August 6, 2007

49.      Malhotra, Girish: Concerns over Akzo buying ICI GLG Group Analysis August 20, 2007

50.      Malhotra, Girish: Pharmaceuticals, Profitability through Simplicity, October 5, 2007

51.      Malhotra, Girish: API (active pharmaceutical ingredient) and specialty chemical costs, Profitability through Simplicity, October 10, 2007

52.      Malhotra, Girish: Is IT a Catalyst for India’s Drug Industry Growth? Pharmaceutical Manufacturing, October 9, 2007

53.      Malhotra, Girish: Pharmaceutical buzzwords, Profitability through Simplicity, October 13, 2007

54.      Malhotra, Girish: India's contribution to humanity, Profitability through Simplicity, October 24, 2007

55.      Chemical Week: Green Chemistry October 24, 2007 pg.23-26 Chemical Week

56.      Malhotra, Girish: Downsizing, Profitability through Simplicity, October, 27, 2007

57.      Malhotra, Girish: Purchase Power Parity, Profitability through Simplicity, October 29, 2007

58.      Malhotra, Girish: What is India? Profitability through Simplicity, November 3, 2007

59.      Malhotra, Girish: Environmentalism, Technology and Human Life, Profitability through Simplicity, November 15, 2007

60.      Malhotra, Girish: Things we know about drug prices but are afraid to ask, Profitability through Simplicity, November 19, 2007

61.      Malhotra, Girish: Pharmaceuticals, Their Manufacturing Methods, Ecotoxicology, and Human Life Relationship, Pharmaceutical Processing, November 2007 Pg 18-23

62.      Malhotra, Girish Personal Dose: A New Direction and Profit, Drug Discovery and Development, December 1, 2007

63.      Chemical Week: Backlash in the Cards from Indian Plant Effluent Study? December 5, 2007 Page 31 Chemical Week

64.      Malhotra, Girish: Year 2007 in Pharmaceuticals, Profitability through Simplicity, December 11, 2007

65.      Malhotra, Girish: Dow potential acquisition GLG Group Analysis December 17, 2007

66.      Malhotra, Girish: New approach to develop drugs GLG Group Analysis December 20, 2007

67.      Malhotra, Girish: Challenges to Ethical and Generic Drug producers, Profitability through Simplicity, December 23, 2007

68.      Malhotra, Girish: Conversation of ABC, Dec. 2007 Published by EPCOT International

69.      Malhotra, Girish: Implementing QbD: A Step-by-Step Approach, Pharmaceutical Processing, February 2008 Pg 16-18

70.      Malhotra, Girish: Is close good enough? Heparin fiasco, Profitability through Simplicity. February 14, 2008, GLG Group Analysis, March 5, 2008

71.      Malhotra, Girish: Heparin and Quality by design, Profitability through Simplicity, February 26, 2008

72.      Malhotra, Girish: Drug safety, side effects, FDA, and its challenges, Profitability through Simplicity, March 9, 2008

73.      Malhotra, Girish: “Quality by Analysis” cannot compete against “Quality by Design”, Profitability through Simplicity, March 15, 2008 

74.      Malhotra, Girish, Heparin Contamination: effort to maximize profits?, Profitability through Simplicity, March 19, 2008 Malhotra, Girish: New Management style: New experiment in Management?, Profitability through Simplicity, March 23, 2008

75.      Malhotra, Girish: Process Puzzler: Clarify a clogged caustic conundrum – Try Recirculation: Chemical Processing March 2008 pg. 41-42

76.      Malhotra, Girish: Ranbaxy, AstraZeneca, Nexium and NEW opportunities, Profitability through Simplicity, April 16, 2008

77.      Malhotra, Girish: Process Puzzler: Succeed through thick and thin – Maintain the temperature: Chemical Processing April 2008 pg. 45-47

78.      Malhotra, Girish: Suzlon is having Teething Problem, GLG Group Analysis, April 22, 2008

79.      Malhotra, Girish: Paint Cost can be reduced by manufacturing technology innovation, GLG Group Analysis April 23, 2008

80.      Malhotra, Girish: Ranbaxy and Daiichi Sankyo relationship, Profitability through Simplicity, June 11, 2008

81.     Malhotra, Girish: Pharmaceutical Manufacturing: Is it the antithesis of Creative Destruction? Pharmaceutical Manufacturing, July 2008

82.      Malhotra, Girish: Opportunities for Private Equity firms in India GLG Group Analysis, July 4, 2008, Profitability through Simplicity, July 10, 2008

83.      Malhotra, Girish: Opportunities for the Pharmaceuticals to improve their manufacturing technology, GLG Group Analysis, July 22, 2008

84.      Malhotra, Girish: Reshuffling of the global pharmaceutical drug deck, Profitability through Simplicity, July 22, 2008

85.      Malhotra, Girish: Pharmaceutical business strategy, GLG Group Analysis, August 7, 2008

86.      Manufacturing: As Ranbaxy’s World Turns, So Does Generics Model July/August 2008 pg. 12-14

87.      Malhotra, Girish: Pharmaceutical companies and their effort to improve profits, GLG Group Analysis,September 11, 2008

88.      Malhotra, Girish: Ranbaxy citations can be an excellent opportunity, Profitability through Simplicity, September 17, 2008, GLG Group Analysis, September 18, 2008

89.      Malhotra, Girish: Pharma Convergence: Challenges in Drug Development and Manufacturing Methods, CHEManager Europe 10/2008, September 18, 2008, pg. 26

90.      Malhotra, Girish: API Manufacturing: A Road Map for Green Chemistry and Processes: pharmaQbD.com October 14, 2008

91.     Malhotra, Girish: Is Pharma Consolidation on Horizon, GLG Group Analysis, October 28, 2008, Profitability through Simplicity, November 4, 2008

92.     Malhotra, Girish: Process Puzzler: Quell a quality control confrontation- Improve the Design: Chemical Processing November 2008 pg. 40-42

93.     Malhotra, Girish: APIs Simplicity by Design. A Low-tech Approach for Quality and Profitability, Mastering Process Chemistry, Philadelphia, November 17-19, 2008

94.     Malhotra, Girish: Is Auto Bailout a prelude for others to ask for help and an admission of “lack of vision”? Profitability through Simplicity, November 23, 2008

95.     Malhotra, Girish: Is "Creative Destruction" the way to go for the Pharmaceuticals? GLG Group Analysis, December 10, 2008, Profitability through Simplicity, December 12, 2008

96.     Malhotra, Girish: Process Puzzler: Get out of the Soup, Chemical Processing, December 2008 pg. 28

97.     Malhotra, Girish: Forget Bail Out or Hand Out - the Answer is Innovation and Conservation, Profitability through Simplicity, January 1, 2009, Chemical Week, January 9, 2009

98.     Malhotra, Girish: ISP: A Hidden ‘Diamond in the Rough’ Chemical Week, Profitability through Simplicity, January 13, 2009

99.      Malhotra, Girish: Pfizer/Wyeth and GSK/UCB GLG Group Analysis January 26, 2009

100.    Malhotra, Girish: Commoditization of Drugs, Chemical Week, Profitability through Simplicity, February 4, 2009

101.    Malhotra, Girish: Why Have the Fine and Specialty Chemical Sectors Been Moving from Developed Countries? Chemical Week, Profitability through Simplicity, February 9, 2009

102.    Malhotra, Girish: Dow and ROH GLG Group Analysis February 9, 2009

103.    Malhotra, Girish: Alphabet Shuffle: Moving From QbA to QbD - An Example of Continuous Processing, Pharmaceutical Processing, February 2009 pg. 12-13

104.    Malhotra, Girish: A Fine Chemical Version of Chernobyl? Chemical Week, Profitability through Simplicity, February 26, 2009

105.    Malhotra, Girish: Pfizer, Generics and Commoditization GLG Group Analysis March 3, 2009

106.    Malhotra, Girish: Rx for Pharma, Chemical Engineering Progress, March 2009, Vol. 105, No. 3 Pg. 34-38

107.    Malhotra, Girish: Global Fine/Specialty Chemical Industry and its Challenges, Profitability through Simplicity, March 5, 2009

108.    Malhotra, Girish: The Challenge for Fine and Specialty Chemical Firms, Chemical Week, March 19, 2009

109.    Malhotra, Girish: Pharmaceuticals and Return on Investment (ROI), 2009, Chemical Week, Profitability through Simplicity, March 26

110.    Malhotra, Girish: The Nano: The New iPod of the Manufacturing Industry? March 27, 2009 Chemical Week, Profitability through Simplicity

111.    Malhotra, Girish: Pharmaceuticals in Water, Profitability through Simplicity, April 24, 2009

112.    Malhotra, Girish: The Art of API Process Simplification and Scale-Up leading to QBD, Quality by Design Conference, International Pharmaceutical Academy, Toronto, April 27, 2009

113.    Malhotra, Girish Process Puzzler: Kayo a Cascade Control Complication Chemical Processing May 2009 Pg. 43

114.    Malhotra, Girish: Process of Continuous Improvement and Pharmaceuticals, GLG Group AnalysisProfitability through Simplicity, June 1, 2009

115.    Malhotra, Girish: What is Holding Back Quality by Design? Chemical Week, Profitability through Simplicity, June 15, 2009

116.    Malhotra, Girish: Recycling Coatings: An Environmental and Business Opportunity, Chemical Week, Profitability through Simplicity, July 8, 2009

117.    Malhotra, Girish: Hesitation In The Drive To A Continuous Pharmaceutical Manufacturing Process: Real or Imaginary? Pharmaceutical Processing, July 2009 pg. 12-15

118.    Malhotra, Girish: Climate Change and its Impact on Industrial Production, Chemical Week, GLG Group Analysis, Chemical Processing, Profitability through Simplicity, August 3, 2009

119.    Malhotra, Girish: Chemical Engineering: Understanding the Curriculum for Quality Manufacturing, Chemical Week, Chemical Processing, Profitability through Simplicity, August 5, 2009

120.    Malhotra, Girish: A Pharmaceutical Challenge for Technocrats, Chemical Week, Chemical Processing, Profitability through Simplicity, August 21, 2009

121.    Malhotra, Girish: Photographs, World Photographers Organization, Volume 1, August 2009 pages 6, 13, 14, 15

122.    Malhotra, Girish: Fine Chemicals: Quality Manufacturing and Technology Innovation in Pharmaceuticals, Chemical Week, Profitability through Simplicity, September 25, 2009

123.    Chemical Week, Cost Cutting Becomes the Pharma Industry’s Mantra Chemical Week, October 5, 2009 pg. 24-28

124.    Malhotra, Girish: Understanding QbD Requires Basic Fundamentals
http://blog.pharmtech.com/ October 13, 2009

125.    Malhotra, Girish: Photographs, World Photographers Organization, Volume 2, October 2009 page 9

126.    Malhotra, Girish: QBA and Elements of QBD, Quality by Design, Challenges of implementing QbD / PAT in the development of rugged and robust formulations, processes, and Approvals October 19-20, 2009, Somerset, NJ

127.    Malhotra, Girish: Exploitation of QBA Elements for a Batch/ Continuous Process, Quality by Design, Challenges of implementing QbD / PAT in the development of rugged and robust formulations, processes, and Approvals October 19-20, 2009, Somerset, NJ

128.    Malhotra, Girish: An Interpretation of U.S. FDA Guidance for Pharma Manufacture, Chemical Week, Profitability through Simplicity, October 19, 2009

129.    Malhotra, Girish: Review of Continuous Process for Modafinil, Continuous Processing in the Chemical and Pharmaceutical Industry II, 2009 AIChE Annual Meeting, November 10, 2009,Nashville, TN.

130.    Malhotra, Girish: Analysis of API (Omeprazole): My perspective, Poster Session: Pharmaceutical Engineering, 2009 AIChE Annual Meeting, November 11, 2009, Nashville, TN.

131.    Malhotra, Girish: What is Jugaad - a New Management Fad from India? Chemical Week, Chemical Processing, Profitability through Simplicity, December 10, 2009

132.    World Images Today, World Photographers Organization, December 2009, pg. 14, 19-21

133.    Malhotra, Girish: A Radical Approach to Fine/Specialty API Manufacturing Chemical Week, Profitability through Simplicity, January 20, 2010

134.    Malhotra, Girish: Pharmexcil to invite drug regulators from Africa for brand buildup GLG Group Analysis January 28, 2010

135.    Malhotra, Girish: HIV Drug Availability and Potential Manufacturing Opportunities, Chemical Week, Profitability Through Simplicity, February 2, 2010

136.    Malhotra, Girish: World Images Today February 2010, pg. 55

137.    Malhotra, Girish: Pharmaceutical Costs, Technology Innovation, Opportunities and Reality, Pharmaceutical Processing February 2010 pg.. 20-24

138.    Green Chemistry: Lighting Up New Pharma Pathways, Chemical Week March 15, 2010, pgs.. 21-23

139.    Malhotra, Girish: Relationship between Big Pharmaceuticals and the Indian Pharmaceuticals, GLG Group Analysis March 15, 2010

140.    Malhotra, Girish: Alternate Interpretation of Pharmaceutical TLAs: Three-letter Acronyms Chemical Week, Profitability through Simplicity, Pharmaceutical Processing, March 16, 2010

141.    Malhotra, Girish: Sanofi-Aventis Expansion in India, GLG Analysis, March 23, 2010

142.    Malhotra, Girish: Process Centricity is the Key to Quality by Design, Pharmaceutical Processing, Chemical Week, Profitability through Simplicity April 6, 2010

143.    Malhotra, Girish: Webinar: Simplifying Coating Formulations for Easier Scale-up Webinar, www.specialchem.com April 27, 2010 

144.    Malhotra, Girish: Microscopic Examination of Indian Pharmaceutical Acquisitions by Multinational Companies, Profitability through Simplicity, Chemical Week, GLG Analysis, May 25, 2010

145.    Malhotra, Girish: You’re the CEO: Can You Justify the Costs of These QbD Projects?www.pharmaqbd.com June 4, 2010 

146.    Malhotra, Girish: Pharmaceutical Reverse Payments and Lower Drug Costs: An Interesting Dilemma, Profitability through Simplicity, Pharmaceutical Processing, Chemical Week, July 21, 2010

147.    Malhotra, Girish: The Path Towards Continuous Processing, Pharmaceutical Processing, August 2010, pgs. 16-20

148.    Malhotra, Girish: Square Plug In A Round Hole: Does this Scenario Exist in Pharmaceutical? Profitability through Simplicity, Pharmaceutical Processing, Chemical Week, August 17, 2010

149.    Malhotra, Girish: The Importance of Fundamentals, Pharmaceutical Processing, Profitability through Simplicity, Chemical Week, August 31, 2010

150.    Malhotra, Girish: Are The Rules A Constraint to Innovation, Competition and A Cause of Adulterated Product? Profitability through Simplicity, Pharmaceutical Processing, Chemical Week, October 1, 2010

151.    Chemical Week: Pharmaceuticals Counterfeiting Drives Change, Chemical Week, September 27/October 4, 2010 pgs. 48-50

152.    Malhotra, Girish: QbA--> QbD Imagination and Creativity Challenge, 5th International Conference and Exhibition, Process Analytical Technologies in Organic Process R&D, November 2, 2010, Clearwater, Florida

153.    Malhotra, Girish: Pharmaceutical Companies Can innovate If They Want to, Profitability through Simplicity, Pharmaceutical Processing, Chemical Week, October 15, 2010

154.    Malhotra, Girish: Comments on PAT Article, Chemical Engineering, pg. 6, October 2010

155.    Malhotra, Girish: Process Puzzler: Deal with a Decanter that C’ant, Chemical Processing, November 2010

156.    Malhotra, Girish: Constructive Destruction in Pharmaceutical Industry, GLG Group Analysis, December 13, 2010

157.    Malhotra, Girish: Mr. Claus, Tear Down These Walls! PharmaQbD.com, December 16, 2010, Pharmaceutical Manufacturing Page 10, January 2011

158.    Malhotra, Girish: Chemical Process Simplification: Improving Productivity and Sustainability, ISBN: 978-0-470-48754-9, Hardcover, 282 pages, January 2011, John Wiley & Sons Inc.

159.    Malhotra, Girish: Inefficiency in Fine Chemicals Manufacture Set to Grow, Chemical Week, February 1, 2011

160.    Malhotra, Girish: Are Patents a Double-Edged Sword? Perspective Matters, Profitability through Simplicity, Pharmaceutical Processing, Chemical Week February 8, 2011

161.    Malhotra, Girish: Chapter “Simplified Process Development and Commercialization” in Quality by Design: From Theory to Practice co-published by Parental Drug Association and DHI Publishing© 2011 February 2011 available at www.pda.org

162.    Malhotra, Girish: Strategies to Enhance API Manufacturing: Identifying inefficiencies and optimizing development through quality by design, Business Insights, London, UK March 2011

163.    Malhotra, Girish: QbA-> QbD: An imagination and creativity challenge, Chemica OGGI/ Chemistry TODAY March/April 2011, Vol. 29 n.2, pg. 42-44.

164.    Malhotra, Girish: P&G and Teva is a win-win and Herculean Challenge for Many, GLG Group Analysis, March 26, 2011

165.    Malhotra, Girish: Pharmaceutical Consolidation in the Developed Countries, GLG Group Analysis, March 31, 2011

166.    Malhotra, Girish: Information Challenges for Product, Process Development and Process Design: A Reality Check, Chemical Week, Profitability through Simplicity, Chemical Processing, Pharmaceutical Processing, April 11, 2011

167.    Malhotra, Girish: Opportunities for the Indian Generic Pharmaceuticals, GLG Group Analysis, April 13, 2011

168.    Malhotra, Girish: Pharmaceuticals start their drive to Consolidation, GLG Group Analysis, May 2, 2011

169.    Malhotra, Girish: Who or What killed QbD? And is there hope for resuscitation? Pharmaceutical Processing, May 2011, pg. 10-14

170.    Malhotra, Girish: Drug Prices: Food vs. Medicine - A Difficult Choice for Some,
Pharmaceutical Processing, Profitability Through Simplicity, Chemical Week, June 17, 2011

171.    Malhotra, Girish: Sun Pharmaceuticals Industries could show Pharma's new course, GLG Group Analysis, July 5, 2011

172.    Malhotra, Girish: Pharmaceutical Quality: Is it a Company or Regulatory Responsibility? August 1, 2011, Profitability Through Simplicity, Pharmaceutical Processing, Chemical Week

173.    Malhotra, Girish: Big Pharma's (Pfizer) First BIG Volley Against Generics, GLG Group Analysis, August 4, 2011

174.    Malhotra, Girish: Generic Drug Fees: A Fantastic Opportunity, August 17, 2011, Profitability Through Simplicity, Pharmaceutical Processing, Chemical Week

175.    Malhotra, Girish: Drug Shortages: Causes and Cures, October 13, 2011
Profitability Through Simplicity, Pharmaceutical Processing, Chemical Week

176.    Malhotra, Girish: Does the Pharmaceutical Industry Need a Steve Jobs? November  9, 2011 Profitability through Simplicity, Pharmaceutical Processing, Chemical Week

177.    Malhotra, Girish: Drugs for Infectious Diseases, Funding and Opportunity, December 11, 2011, Profitability Through Simplicity, Chemical Week, Pharmaceutical Processing

178.    Malhotra, Girish: Manufacturing can address the global disease crisis, G+
December 19, 2011

179.    Pharmaceuticals: Asian Contract Manufacturers Pose Challenge to Western Firms, Chemical Week, pgs. 21-26, Feb6/13, 2012,

180.    Malhotra, Girish: Neglected Tropical Disease Drugs: What are they Telling US About Innovation? March 7, 2012 Profitability through Simplicity, Pharmaceutical Processing, Chemical Week

181.    Malhotra, Girish: Focus on Physical Properties To Improve Processes: Chemical Engineering, Vol. 119 No. 4 April 2012, pgs. 63-66

182.    Malhotra, Girish: Can the Combination of Creative Destruction and “Steve Jobs Traits” Lead to a Pharma QbD Spring? April 16, 2012, Profitability through Simplicity, Pharmaceutical Processing, Chemical Week

183.    Malhotra, Girish: A Guide to QbD for APIs, Pharmaceutical Processing, Volume 27, No. 4 May 2012, pg. 46-49, Pharma Times November 2012 pg. 45-47

184.    Malhotra, Girish: Financial Justification for QbD and Cost of Regulation Compliance Profitability through Simplicity, Pharmaceutical Processing, Chemical Week, May 22, 2012

185.    Malhotra, Girish: Is the New Terminology Going to Make the Pharmaceutical Processes Environmentally Friendly and Economic? Profitability through Simplicity, Pharmaceutical Processing, Chemical Week June 4, 2012

186.    Malhotra, Girish: Is Continuous Processing in Pharma’s Future? Profitability through Simplicity, Pharmaceutical Processing, Chemical Week, July  24, 2012

187.    Malhotra, Girish: Are the Savings of $120-$150 Billion Worth Having? Profitability through Simplicity, Pharmaceutical Processing, Chemical Week, August 30, 2012

188.    Malhotra, Girish: Patents: Should We Change Intellectual Property Model/Strategies? Profitability through Simplicity, Chemical Week, Pharmaceutical Processing, IPSTRATEGY.com October 5, 2012 

189.    Malhotra, Girish: Improving Global Affordability of HIV/AIDS Drugs Through Technology Innovation Profitability through Simplicity, Pharmaceutical Processing, Chemical Week October 19, 2012

190.    Malhotra, Girish: Government of India’s Brand vs. Generics Tell of Today’s Conflicts and Reality Profitability through Simplicity, Pharmaceutical Processing November 15, 2012

191.    Malhotra, Girish: The Op-Ed: Some Indian Drugmakers Need A Fix, www.Pharmalot.com January 9, 2013

192.    Malhotra, Girish: Can Falsified Medicine and Other Directives Backfire? Profitability through Simplicity, Pharmaceutical Processing January 31, 2013 

193.    Malhotra, Girish: The Secret Life of APIs www.pharmaevolution.com February 26, 2013

194.    Malhotra, Girish: The Secret Life of APIs: The Importance of Sociochemicology April 4, 2013

195.    Malhotra, Girish: Sociochemicalogy, www.pharmaevolution.com April 9, 2013

196.    Malhotra, Girish: Lost in Translation? - Can QbD Translate to Jobs in the Pharmaceutical Industry? Pharmaceutical Processing April 17, 2013

197.    Malhotra, Girish: Product Volume & API Process Optimization, www.pharmaevolution.com May 2, 2013

198.    Malhotra, Girish: Improving APIs & Formulation: Are You Harnessing the Power of Liquids? http://www.pharmaevolution.com May 14, 2013

199.    Chemical & Engineering News Volume 91 Issue 21 pp. 30-31 May 27, 2013

200.    Malhotra, Girish: Is it Time to Revamp cGMPs? http://www.pharmaevolution.com May 29, 2013

201.    Malhotra, Girish: QbD: Its Value, Impact and Economics, Pharma-QbD Forum, June 12-14, 2013, The Lalit, Mumbai India

202.    Malhotra, Girish: The Art of API Simplification and QbD based Manufacturing, Pharma-QbD Forum, June 12-14, 2013, The Lalit, Mumbai India

203.    Malhotra, Girish: QbD on the Menu at CPhI Mumbai: Industry Savings of $200 Billion Possible, June 19, 2013, www.pharmaevolution.com

204.    Malhotra, Girish: Can Clinton/Gates Save Pharma? www.pharmaevolution.com June 24, 2013

205.    Malhotra, Girish: Letter to Indian Pharma CEOs: Have You Lost Your Chance to Innovate? www.pharmaevolution.com July 26, 2013

206.    Malhotra, Girish: Increasing Profits by Reaching Pharma’s Silent Majority, http://www.pharmaevolution.com August 5, 2013

207.    Malhotra, Girish: Shift to continuous process from batch and reap the benefits, Chemical Industry Digest, Vol.XXVI 8, August, 2013, pg. 7

208.    Malhotra, Girish: Conflicts and opportunities in the Life of APIs, Chimica Oggi-Chemistry Today Vol. 31 (4) July/August 2013 pgs. 10-13

209.    Malhotra, Girish: Imagine… a Process-Centered Pharma www.pharmaevolution.com September 11, 2013

210.    Malhotra, Girish: Millions? Billions? Millions? Billions? A Matter of Perspective  September 21, 2013 www.pharmaevolution.com

211.    Malhotra, Girish: CPhI Pharma Evolution Annual Industry Report part 2, pgs. 22-25 October 2013

212.    Malhotra, Girish: The Nail That Sticks Out Could Change the World: When Culture Stifles Innovation, www.pharmaevolution.com November 14, 2013

213.    Malhotra, Girish: Break the Rag Layer, Chemical Processing Process Puzzler, November 2013, Page 50

214.    Malhotra, Girish: Indian Producers have to Consider a Process Centric Model, www.pharma.financialexpress.com page 58, 61, November 2013

215.    Malhotra, Girish: Could the Google Books Decision Set a Precedent for Global Pharma Patents? http://www.pharmaevolution.com December 10, 2013

216.    Malhotra, Girish: Revamp the Process, Chemical Processing, Process Puzzler, December 2013 Page 32

217.    Malhotra, Girish: Can Emerging Pharma's Leadership Move On to the Next Stage? www.pharmaevolution.com December 18, 2013

218.    Malhotra, Girish: Reading the Tea Leaves: Predictions for Pharma's Future, www.pharmaevolution.com January 15, 2014

219.    Malhotra, Girish: Will Pharma's Global Customers Redefine Maslow’s Hierarchy of Needs? www.pharmaevolution.com January 27, 2014

220.    Malhotra, Girish: What Do The Recent Ranbaxy Citations Teach Us? Profitability through Simplicity, February 4, 2014

221.    Malhotra, Girish: Safety and Safe Practices in Chemical Manufacturing, March 17, 2014 Presented at Cleveland State University Senior Class

222.    Malhotra, Girish: Ranbaxy: Lessons and Opportunities, Contract Pharma, April 9, 2014, Contract Pharma, May, 2014 pg. 28-29

223.    Malhotra, Girish: Sun Pharma’s Exotic Challenge: How Real?, Profitability through Simplicity, April 23, 2014

224.    Malhotra, Girish: API Manufacturing’s Stuck in the Mud. Pharmaceutical Manufacturing, May 2014 pg. 42

225.    Malhotra, Girish: Toward a Process-Centered Pharma, Contract Pharma, Vol.16, 5, Pg 46-48, June 2014

226.    Malhotra, Girish: INJECT THE WAX AT THE PUMP, Chemical Processing, July 10, 2014

227.    Malhotra, Girish: Why Fitting a Square Plug in a Round hole is Profitable for Pharma and Most Likely Will Stay? Profitability through Simplicity, Pharmaceutical Processing, August 1, 2014

228.    Malhotra, Girish: Landscape Disrupters Are Becoming Part of the Pharma’s Playing Field, Profitability through Simplicity, August 17, 2014

229.    Malhotra, Girish: Are Toyota’s manufacturing practices the right benchmark for the pharma? Chemica Oggi-Chemistry Today, Vol. 32(4), pg. 2-3,July/August 2014

230.    Malhotra, Girish: A Blueprint for Improved Pharma Competitiveness, Contract Pharma, Vol. 16, 7, Pg. 46-49, September 2014 

231.    Malhotra, Girish: Is McLaren Going to be Pharma’s “Creative Destructionist”? Profitability through Simplicity, October 14, 2014

232.    Malhotra, Girish: Regulatory Compliance vs. Operational Excellence: What Should Happen First? Profitability through Simplicity, February3, 2015

233.    Malhotra, Girish: Compliance vs. Operational Excellence, Pharmaceutical Manufacturing, pg. 50, March 2015

234.    Malhotra, Girish: Could Pharma’s New Movers and Shakers Make a Difference? Profitability through Simplicity, April 24, 2015

235.    Malhotra, Girish: May Day May Day: Can Someone Help and Lower Drug Prices? Profitability through Simplicity, May 1, 2015

236.    Malhotra, Girish: How to Justify Innovation and QbD in Manufacturing, Pharmaceutical Manufacturing, May 4, 2015 Pg. 35-36

237.    Malhotra, Girish: Continuous Process in Pharmaceutical Manufacturing: Considerations, Nuances and Challenges, Contract Pharma, June 2, 2015

238.    Malhotra, Girish: Can An Alliance Between US Pharmaceutical Benefit Managers (1) and Make in India (2) Lead to Lower Global Drug Prices?, Profitability through Simplicity, June 17, 2015

239.    Malhotra, Girish: Are Software Technologies Going to be Pharma’s Creative Destructionists?, Profitability through Simplicity, July 14, 2015

240.    Malhotra, Girish: Impact of 21CFR 314.70 on The Life of a Pharmaceutical Manufacturing Process, Profitability through Simplicity, August 7, 2015

241.    Malhotra, Girish: Could Software Technologies be the “Creative Destructionist” for Pharmaceuticals and Chemicals?, Profitability through Simplicity, August 31, 2015

242.    Malhotra, Girish: Manufacturing technologies and their part to achieve future pharmaceutical sales, Chemica Oggi Chemistry- Today, September/October 2015 Vol. 33(5) pg. 28-31

243.    Malhotra, Girish: My perspective for Pharmaceutical Manufacturing Technologies/Processes and Continuous Improvements, CPhI 2015, http://epcotint.com/Pharmaevolution/GirishMalhotraSeptember2015CPhIreport.pdf 

244.    Malhotra, Girish: Is Pharma’s Goal to Serve Patients Per Billion or Million? Profitability through Simplicity October 2, 2015

245.    Malhotra, Girish: Mitigate a Manager’s Mayhem: Go Back to Original Design, Chemical Processing, October 2015 

246.    Malhotra, Girish: Cleveland State University, Lecture to Two Senior Classes, Social Behavior of Chemicals, October 21, 2015

247.    Malhotra, Girish: Calling for Change, Profitability through Simplicity, November 17, 2015

248.    Malhotra, Girish: Is FDA Rule 21CFR314.70 a Case of “Shackled Freedom” for Pharmaceutical Manufacturing?, Profitability through Simplicity, Pharmaceutical Processing, November 19, 2015

249.    Malhotra, Girish: Who Is/Or Should Be Driving Pharma’s Manufacturing Car: Regulators or the Regulated? Profitability through Simplicity, December 7, 2015

250.    Malhotra, Girish: Pharma’s Landscape’s going to look a lot different in 2026 http://www.pharmamanufacturing.com/articles/2016/pharma-landscape-2026/ February 5, 2016

251.    Malhotra, Girish: Continuous Pharmaceutical Processes and Their Demands, Contract Pharma, pg. 37-40, April 5, 2016

252.    252.Malhotra, Girish: Can Senate And House Bills S2615 And HR 4784 [Increasing Competition in Pharmaceuticals Act] Alter the Pharmaceutical Landscape?, Profitability through Simplicity, May 26, 2016

253.    Malhotra, Girish: Pharmaceutical Process:  Batch or Continuous Reality, Myth or Imagination, Contract Pharma: 2016 Contracting and Outsourcing Conference, New Brunswick, September 23, 2016  

254.    Malhotra, Girish: Manufacturing Processes Require Financial Justification, CPhI, September 26, 2016 pgs12-14

255.    Malhotra, Girish: Manufacturing Processes Require Financial Justification, Contract Pharma, CPhI Annual Industry Report 2016: Expert Contribution, September 27, 2016

256.    Malhotra, Girish: Financial Justification in Pharma, Pharmaceutical Manufacturing, Volume 15, Issue 9, November 4, 2016

257.    Malhotra, Girish: Process Innovations: Who Should Lead & Their Impact?, Contract Pharma, November 9, 2016 Vol. 18 No. 9, pg. 69-71 

258.    Malhotra, Girish: Industry 4.0 (Digitization): Its Benefits to Pharma and Other Chemical Industries, Profitability through Simplicity, November 11, 2016

259.    Malhotra, Girish: Opportunity to showcase excellence and drive forward industry standards: the CPhI Awards, Chemica Oggi-Chemistry Today, Vol 34(6), November/December 2016, pgs. 64-65

260.    Malhotra, Girish: Develop A Dialog, Chemical Processing, December 2016, Vol. 78, Issue 12 

261.    Malhotra, Girish: Can Uniform Safety, Health and Effluent and Manufacturing Standards Create Process Technology Innovation and Competition in Pharmaceuticals? Profitability through Simplicity, January 10, 2017

262.    Malhotra, Girish: Pharmaceutical Sales Forecasts: Fiction, Facts or Alternate Facts, Profitability through Simplicity, February 9, 2017

263.    Malhotra, Girish: Manufacturing processes require financial justification, Chemica Oggi - Chemistry Today, Vol. 35 January/February 2017, pg. 38-39

264.    Malhotra, Girish: Process Simplification and The Art of Exploiting Physical Properties, Profitability through Simplicity, March 10, 2017 

265.    Malhotra, Girish: Strategies for Improving Batch or Creating Continuous Active Pharmaceutical Ingredient (API) Manufacturing Processes, Profitability through Simplicity, March 20, 2017

266.    Malhotra, Girish: Can the Review and Approval Process for ANDA at USFDA be Reduced from Ten Months to Three Months?, Profitability through Simplicity, March 25, 2017

267.    Malhotra, Girish: Reality and Un-Reality: Continuous Processing in Pharmaceutical Manufacturing, Contract Pharma, April 3, 2017

268.    Malhotra, Girish: Would The Coating Industry’s Consolidation Lead to Manufacturing Innovation? Profitability through Simplicity, April 26, 2017

269.    Malhotra, Girish: ANDA (Abbreviated New Drug Application) / NDA (New Drug Applications) Filing Simplification: Road Maps are a Must., Profitability through Simplicity, May 11, 2017

270.    Malhotra, Girish: Kudos For Research, Chemical Processing, June 2017, Pg 47

271.    Malhotra, Girish: The Medicine Maker Issue #0617, Calling for ANDA Action, June 2017

272.    Malhotra, Girish: Batch, Continuous or "Fake/False" Continuous Processes, Profitability through Simplicity, July 20, 2017, American Pharmaceutical Review, Vol. 20 Issue 6 September/October 2017 pgs. 86-91, Contract Pharma, Nov./Dec. 2017 pgs. 56-58, Chemistry Today, November/December 2017, Vol. 35(6) pgs. 62-65

273.    Malhotra, Girish: An Alternate Look at the Pharmaceutical World Revenues and Drug Affordability, Pages 2-5, CPhI 2017 Annual Report, www.gmpnews.net, Autumn 2017, Manufacturing Chemist, Volume 88, Number 10, October 2017, Pg. 28-32

274.    Malhotra, Girish: Innovation In Pharmaceuticals: What Would It Take & Who is Responsible?, Profitability through Simplicity, November 28, 2017

275.    Malhotra, Girish: Pharmaceutical Manufacturing Technology Innovation: Does Reading the Tea Leaves Matter? Profitability through Simplicity, December 22, 2017

276.    Malhotra, Girish: Forget About and Easy Fix, An Essential Question, Chemical Processing, December 2017, Pg 32

277.    277.Malhotra, Girish: Comparison of Drugs Prices: US vs. India; Their Manufacturing Costs & Opportunities to Improve Affordability, Profitability through Simplicity, January 18, 2018

278.    Malhotra, Girish: Could Amazon (A), Berkshire Hathaway (B) and J.P. Morgan Chase (M) be the Anti Ballistic Missile (ABM) needed to Control/Curb Rising Healthcare Costs? Profitability through Simplicity, February 9, 2018: Healthcare Costs Run Rampant, Contract Pharma, March 2018, Vol. 20, No. 2 Pg 32-34 

279.    Girish Malhotra: Opportunities to Lower Drug Prices and Improve Affordability: From Creation (Manufacturing) to Consumption (Patient), Profitability through Simplicity, March 9, 2018, Contract Pharma,  May 8, 2018, gmpnews.net, Pgs.44-47, No. 1(2) 2018

280.    Malhotra, Girish: The Good, The Bad, and The Ugly1 Complexities of the Pharmaceutical Manufacturing, Profitability through Simplicity, April 9, 2018, Contract Pharma June 2018 Vol. 20 No.5

281.    Video: Continuous Pharmaceutical Manufacturing: American Pharmaceutical Review, April 17, 2018

282.    Malhotra, Girish: Learn Some Lessons, Chemical Processing, April, 2018 pg. 22

283.    Continuous Processing Roundtable, American Pharmaceutical Review, https://www.americanpharmaceuticalreview.com/Continuous-Processing/, https://www.americanpharmaceuticalreview.com/Featured-Articles/349412-Continuous-Processing/, pgs. 54-58, April 2018

284.    Malhotra, Girish: Improving Drug Affordability for the United States Populous through Alternate Business Models, Profitability through Simplicity, May 4, 2018; American Pharmaceutical Review, Vol 21 Issue 4, Pg. 12-14

285.    Malhotra, Girish: Amazon PillPack Marriage can Alleviate Drug Shortages and May be Lower Drug Prices, Profitability through Simplicity, July 5, 2018

286.    Malhotra, Girish: Pharma’s future is putting innovations in the hands of innovators, CPhI Annual Industry Report 2018, August 23, 2018, Contract Pharma, September 11, 2018 pgs. 30-34

287.    Malhotra, Girish: Past, Present and Future in Pharmaceuticals, Profitability through Simplicity, October 5, 2018

288.    Malhotra, Girish: A 20 Year Retrospective: The Pharmaceutical Industry Then and Now, American Pharmaceutical Review, October 15, 2018

289.    Malhotra, Girish: Keeping Innovation in our Hands, Pharmaceutical Manufacturing, Pg. 42, October 2018

290.    Malhotra, Girish: What Is Needed for a Regulatory Approval of NDA/ANDA Filings in 90 Days? Profitability through Simplicity, October 24, 2018

291.    Malhotra, Girish: Quick Review of Chemicals Related Process Development, Design and Scale up Considerations, Profitability through Simplicity, November 7, 2018

292.    Malhotra, Girish: Take a Cold-Eyed Look at a Cooling Problem, Chemical Processing, November 2018 pgs. 43

293.    Malhotra, Girish: Simplified Roadmap for ANDA/NDA Submission and Approval will change Pharma Landscape, Profitability through Simplicity, November 25, 2018

294.    Malhotra, Girish: Identifying the Root Causes of Drug Shortages and Finding An Enduring Solution,Profitability through Simplicity, December 7, 2018, Pharmaceutical Processing, December 10, 2018

295.    Malhotra, Girish: Weigh The Cause Of Feeder Problems, Chemical Processing, pg.32, December, 2018

296.    Malhotra, Girish: Set Up An Internal Team, Process Puzzler, Chemical Processing, February 2019

297.    Malhotra, Girish: Impact of Regulations, Drug Manufacturing and Pharma Supply Chain (PBMs and allies) in Drug Shortages and Affordability, Profitability through Simplicity, March 8, 2019

298.    Malhotra, Girish: Impact of Regulations, Manufacturing and Pharmaceutical Supply Chain (PBMs) on Drug Shortages and Affordability: Part 2: Profitability through Simplicity, April 3, 2019

299.    Malhotra, Girish: Delve Deeper, Chemical Processing, April 9, 2019

300.    Malhotra, Girish: Considerations to Simplify Organic Molecule (API) Manufacturing Processes: My perspective, Profitability through Simplicity, April 20, 2019

301.    Malhotra, Girish: Opportunities for Generic Pharma to Clear the Quality Stigma, Profitability through Simplicity, May 23, 2019

302.    Malhotra, Girish: Systematic Demystification of Drug Price Mystique and the Needed Creative Destruction, Profitability through Simplicity, October 2, 2019

303.    Generics drive API growth, Chemical Week, September 23/30 2019, pgs. 32-34

304.    Malhotra, Girish: Are USFDA 483 Citations a “Medal of Honor” or “Rite of Passage” to Disgrace for the Pharma companies? Profitability through Simplicity, October 16, 2019

305.    Malhotra, Girish: Pharmaceutical Quality: Concepts, Misconceptions, Realities and Remedies, Profitability through Simplicity, November 4, 2019

306.    Malhotra, Girish: Drug Shortages, Quality and Prices: Who is Responsible? Profitability through Simplicity, November 6, 2019

307.    Malhotra, Girish: ONE PAGE Road Map to Reduce Drug Shortages, Assure Quality and Improve profitability, Profitability through Simplicity, December 6, 2019

308.    Malhotra, Girish: Talk to the Vendor, Do Cranky Centrifuges Deserve Another Turn?, Chemical Processing, February 2020

309.    Malhotra, Girish: Strategies to Increase Generic Drug Competition and Bring Manufacturing to The United States of America, Profitability through Simplicity, March 16, 2020

310.    Malhotra, Girish: Focus on Quality, Remedy a Recalcitrant Reactor, Chemical Processing Process Puzzler, March 2020, pg. 36

311.    Malhotra, Girish: GDFUA II ANDA (Abbreviated New Drug Application) Review Target of 8-10 Months should be a Cause of Concern, Profitability through Simplicity, March 24, 2020

312.    Malhotra, Girish: How Would US FDA Behave/React if They Were on the Receiving End? Profitability through Simplicity, March 27, 2020

313.    Malhotra, Girish: Long Term Drug Quality Supplies for US, FDA and A New Reality, Profitability through Simplicity, April 3, 2020

314.    Malhotra, Girish: Quash Commissioning Quandaries, Fire THE CEO!, Chemical Processing, Process Puzzler, April 2020, pg. 34

315.    Malhotra, Girish: Does A Double-Wall Tank Make Sense?, Answer Some Key Questions, Chemical Processing, May 2020

316.    Malhotra, Girish: Health and National Security Issues for the USA and is The United States of America Prepared, Profitability through Simplicity, May 8, 2020

317.    Malhotra, Girish: Euphoria to Bring Pharma Manufacturing Home to United States its Reality and Challenges, Profitability through Simplicity, May 23, 2020

318.    Malhotra, Girish: Bring Pharmaceutical Manufacturing Back to USA: Additional Thoughts and Recap, Profitability through Simplicity, May 29, 2020

319.    Malhotra, Girish: A road map for driving pharmaceutical manufacturing back to the USA by 2025, Profitability through Simplicity, October 8, 2020

320.    Malhotra, Girish: Comment posted for Public Health Focused Essential Meds, MCM and Their Critical Inputs List to Address Section 3(c) of EO 13944(1)

321.    Malhotra, Girish: Active Pharmaceutical Ingredient Manufacturing (API) and Formulation Drive to NET ZERO (Carbon Neutral)? Profitability through Simplicity, April 29, 2021

322.    Malhotra, Girish: Climate Change and Greening of Pharmaceutical Manufacturing, Profitability through Simplicity, January 24, 2022  

323.    Malhotra, Girish: Ditch the Dryer, https://www.chemicalprocessing.com/articles/2022/powder-handling-dryer-revamp-demands-care February 13, 2022

324.    Malhotra, Girish: Pharma’s Active Pharmaceutical Ingredient Manufacturing: Their Environmental Impact and Opportunities, Profitability through Simplicity,  March 3, 2022

325.    Malhotra, Girish: US’s Self Sufficiency for Generic Drugs: A Supply Dilemma and Potential Solutions, Profitability through Simplicity, March 31, 2022

326.    Malhotra, Girish: Active Pharmaceutical Ingredient Manufacturing: Nondestructive Creation April 19, 2022 https://www.degruyter.com/document/doi/10.1515/9783110702842/html

327.    Malhotra, Girish: Climate Change & greening of pharmaceutical manufacturing, Specialty Chemicals Magazine May/June 2022 pgs. 26-28

328.    How can pharma achieve ‘Net Zero’? Through driving change in pharma manufacturing https://www.cphi-online.com/how-can-pharma-achieve-net-zero-through-driving-news117631.htmlMay 23, 2022

329.    Malhotra, Girish: Has US lost its Business Acumen, Creativity and Imagination for its Healthcare Needs? Profitability through Simplicity, June 6, 2022

330.    Malhotra, Girish: Sustainable API Manufacturing Podcast June 16, 2022

331.    Malhotra, Girish: Amazon’s Opportunity to be a Generic Drug Player Profitability through Simplicity, August 2, 2022

332.    Malhotra, Girish: Innovation in Pharmaceuticals Manufacturing Technologies, Distribution & Regulations: Are they Easy or a Challenge? Profitability through Simplicity September 26, 2022

333.    Malhotra, Girish: API MANUFACTURING AND ENVIRONMENTAL SUSTAINABILITY Chemistry Today, September/October 2022 Vol. 40(5)

334.    Malhotra, Girish: Comments & Feedback to USFDA on Distributed and POC Manufacturing FDA-2022-N-2316

335.    Malhotra, Girish: Expert Opinion Flow Chemistry in Pharmaceutical Manufacturing. https://www.chemanager-online.com/en/news/expert-statement-girish-malhotra-epcot-internationalJanuary 24, 2023

336.    Malhotra, Girish: Artificial Intelligence in Chemical Process Development, Manufacturing and Net Zero Profitability through Simplicity, March 31, 2023 The Hub Daily News CPHI North America, April 25-27, 2023

337.    Malhotra, Girish: Art and Science of Chemical Process Development & Manufacturing Simplification University of Akron Chemical Engineering Senior Class April 11, 2023

338.    Malhotra, Girish: Art and Science of Chemical Process Development & Manufacturing Simplification Cleveland State University Chemical Engineering Senior Class April 20, 2023

339.    Malhotra, Girish: Should Pharmaceutical Product Quality EVEN be discussed in a public forum? Shouldn’t it be EXPECTED? Profitability through Simplicity, May 12, 2023

340.    Malhotra, Girish: Art and Science of Chemical Process Development & Manufacturing Simplification https://www.aiche.org/ili/academy/webinars/art-and-science-chemical-process-development-manufacturing-simplification May 17, 2023

341.    Malhotra, Girish: Capitalizing on Mutual Behavior and Chemical Reactivity of Chemicals, Profitability through Simplicity May 29, 2023

342.       Malhotra, Girish: Chemicals tell us how to exploit their behavior for better processes. Clues are ignored. Should we? Profitability through Simplicity, June 20, 2023 

343.       Malhotra, Girish: Webinar “The History and Future of Pharmaceutical Industry – focus on small molecule drugs” Central Michigan University College of Medicine.

344.       Malhotra, Girish: Considerations to have an excellent environmentally friendly and economic chemical process? Profitability through Simplicity, August 28, 2023

345.    Malhotra, Girish: Marriage of Science and Technology in Active Pharmaceutical Ingredient (API) Manufacturing and their Formulations: Is it for real? Profitability through Simplicity, September 21, 2023

346.    Malhotra, Girish: Roadmap to Reduce Drug Shortages and Bring Pharma Manufacturing Home (US) Profitability through Simplicity, October 30, 2023 

347.    Malhotra, Girish: USA’s Annual Ritual of Drug Sourcing/pricing and Shortages, Profitability through Simplicity November 25, 2023

348.    Malhotra, Girish: Manufacturing Technology Innovations in Pharmaceutical Manufacturing: Profitability through Simplicity, February 23, 2024

349.    Malhotra, Girish: Use of Tradition, Creativity, Imagination and Technology Innovation in Propofol Manufacturing Profitability through Simplicity, March 21, 2024

350.    Malhotra, Girish: Use of Tradition, Creativity, Imagination and Technology Innovation in Propofol Manufacturing Profitability through Simplicity, April 4, 2024

351.    Malhotra, Girish: USP 11,267,798 B2: Manufacture of Piperine (1) An Excellent Teaching Tool Profitability through Simplicity, June 17, 2024

352.    Malhotra, Girish: Process Simplification and Net Zero: Capitalizing on Physical and Chemical Properties of Reactants and Intermediate, Profitability through Simplicity, August 20, 2024

353.    Malhotra, Girish: Environmental Conservation (Green Chemistry, Net Zero, Decarbonizing) in Active Pharmaceutical Ingredients (APIs) & Fine/Specialty Chemical Manufacturing, Profitability through Simplicity, October 2, 2024 

354.    Malhotra, Girish: Net Zero for Active Pharmaceutical Ingredient & Fine/Specialty Chemicals: Non Destructive Creations, Profitability through Simplicity, November 7, 2024

355.    Malhotra, Girish: Process Simplification: Is the Best Answer: New Terminologies or the Application of Fundamentals? Profitability through Simplicity December 14, 2024

356.    Malhotra, Girish: An Update: Artificial intelligence in Pharmaceutical/Chemical Process Development, Manufacturing & Net Zero [Post of March, 31, 2023], Profitability through Simplicity, February 14, 2025

357.    Malhotra, Girish: Sociochemicology: Redefining Chemical Process Design for Efficiency and Sustainability, Profitability through Simplicity, February 26, 2025

358.    Malhotra, Girish: Net Zero for APIs, Specialty Chemical Magazine March/April 2025 pg. 24-26

359.    Malhotra, Girish: Remedy of US’s Drug Supply Chain Shortages and Domestic Production of Generic and Brand Drugs, Profitability through Simplicity, April 15, 2025 

360.    Malhotra, Girish: An Outlier Plan to Bring Pharmaceutical Manufacturing to USA in One Year, Profitability through Simplicity, April 28, 2025 

361.    Malhotra, Girish: Implementing Executive Orders on Domestic Production of Critical Medicines and Achieve Most Favored Nation Pricing, Profitability through Simplicity, June 11, 2025

362.    Malhotra, Girish: An Unconventional Analysis: Can the Wrath of Most Favored Nation Pricing (1) be Avoided by Bringing Pharmaceutical Product & Process Development and Manufacturing Practices to 21st Century? Profitability through Simplicity, July 8, 2025

363.    Malhotra, Girish: Most Favored Nation Pricing & Bringing Pharmaceutical Manufacturing Home, Profitability through Simplicity, July 13, 2025

364.    Malhotra, Girish: Executive Order 14293 & FDA Processes, Profitability through Simplicity, August 8, 2025  

365.    Malhotra, Girish: Physical Properties of Chemicals, their Mutual Behavior i.e. SOCIOCHEMICILOGY and Process Simplification, Profitability through Simplicity, September 8, 2025

366.    Malhotra, Girish: Let us "THINK DIFFERENTLY'. It is time especially for pharmaceuticals, Profitability thorough Simplicity, September 23, 2025 

367.    Malhotra, Girish: FDA’s ANDA Prioritization Pilot and Possibilities of its Success, Profitability through Simplicity October 7, 2025 

368.    Malhotra, Girish: For Domestic Pharma Manufacturing: Reorganize CDER, Profitability through Simplicity, November 6, 2025

369.    Malhotra, Girish: Revised UPDATE: US Domestic Generic Pharma Manufacturing needs Shorter Approval Time and Lower ANDA Fee, Profitability through Simplicity, December 18, 2025

370.    Malhotra, Girish: Imagination, Creativity and Sociochemicology (1) in Chemical Process Development, Profitability through Simplicity, January 10, 2026

371.    Malhotra, Girish: SOCIOCHEMICOLOGY: Designing Chemical Processes by Exploiting the Social Behavior of Molecules, Profitability through Simplicity, February 22, 2026  

372.    Malhotra, Girish: The Process Development Triumvirate: Profitability Through Simplicity, Profitability through SimplicityMarch 24, 2026

373.    Malhotra, Girish: Exploitation and Capitalization of Mutual Behavior of Chemicals (Sociochemicology) and Process Equipment for the Manufacture of Propofol, Profitability through Simplicity, May 5, 2026

374.    Malhotra, Girish: Sociochemicology: Its Birth and Value, Profitability through Simplicity, June 29, 2026

375.   Malhotra, Girish: Role of Village and Triumvirate in Process Development of Isoniazid :- a Tuberculosis Drug, Profitability through Simplicity, September 29, 2026

 

AWARDS AND HONORS

Sherwin Williams Co. President’s Cost Reduction Awards 1979 and 1982

 

PROFESSIONAL ASSOCIATION MEMBERSHIPS AND AFFILIATIONS



 

·       Member Advisory Board TwoFour Insight Group LLC. January 2014- May 2016


·       Member Scientific Advisory Board chemica oggi Chemistry Today 2014 - 2017


·       Online Advisory Board Chemical & Engineering News American Chemical Society (2102-2015)

·       Editorial Advisory Board Pharmaceutical Processing Magazine 2006- 2020


·       Editorial Advisory Board Pharmaceutical Manufacturing Magazine 2010- Present


·       Editorial Advisory Board www.pharmaqbd.com 2011- 2017


·       Member CPhI Worldwide Expert Industry Panel 2013-2021


·       Judge CPhI Awards panel 2016, 2017, 2018


·       Editorial Advisory Board GMPNEWS.NET 2019-2022


·       Ask the Expert “Process Simplification” Chemical Processing Magazine


·       Ask the Expert “API Manufacturing” Pharmaceutical Manufacturing Magazine


·       Registered Professional Engineer in States of Illinois (73-Present) and Ohio (76-present)

·       Association of Consulting Chemists and Chemical Engineers 1996-2018 


·       American Institute of Chemical Engineers 1967 - Present


·       Bemis Co. Rep - Industrial Research Institute ‘91-’96


·       Toastmasters ’94-’98


·       Who’s Who
Member: Chemical Engineering Product Research Panel 1975-1977

   

EDUCATION AND TRAINING



 

·       MBA Program; Xavier University - Cincinnati, OH; 1977-1979


·       M. S. Chemical Engineering; Clarkson University - Potsdam, NY; 1968 (Thesis: Effect of pulsations on laminar flow in porous conduits)


·       Graduate Diploma; Petroleum Refining; Indian Institute of Petroleum – India, 1966 


·       B. S. Chemical Engineering; Harcourt Butler Technological Institute – India, 1965
Seminars in:  Drug delivery systems, radiation curing, pressure sensitive and release technologies, technology management, digital imaging, and crystallization 

 

COMMUNITY AND PERSONAL ACTIVITIES



 

·       Junior achievement counselor


·       CPR trainer


·       Judge Intel International Science and Engineering Fair 2003, Cleveland, OH


·       Member Community Emergency Response Team 2021 -present

·       Holden Arboretum 2018- 2021


·       Mentor College Now 2020-2029


·       Mentor True2U
2019

·       Member Rotary Club of Chagrin Highlands 2019 - present